Free Trial

IperionX Limited Sponsored ADR (NASDAQ:IPX) Stock Now Rated "Moderate Buy" by Wall Street Analysts

IperionX logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts rate IperionX a “Moderate Buy”: Six of seven covering brokerages recommend buying the stock, while one rates it a sell; the average 12-month price target is $42.
  • The shares have fallen sharply: IPX opened at $14.10, versus a 52-week range of $12.14 to $61.45, and its 50- and 200-day moving averages were $17.29 and $29.64, respectively.
  • IperionX is developing U.S.-based titanium resources and lower-energy processing technologies; institutional investors own 2.76% of its shares, and several reported increasing or initiating positions.
  • Five stocks we like better than IperionX.

IperionX Limited Sponsored ADR (NASDAQ:IPX - Get Free Report) has received a consensus rating of "Moderate Buy" from the seven brokerages that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation and six have issued a buy recommendation on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $42.00.

A number of equities analysts have commented on IPX shares. Jefferies Financial Group began coverage on shares of IperionX in a research note on Wednesday, September 2nd. They set a "buy" rating and a $26.00 target price on the stock. B. Riley Financial lowered their target price on shares of IperionX from $52.00 to $34.00 and set a "buy" rating for the company in a research note on Wednesday, September 30th. Roth Capital set a $53.00 price target on shares of IperionX in a research note on Wednesday, August 5th. Finally, Weiss Ratings reissued a "sell (e+)" rating on shares of IperionX in a report on Thursday, October 15th.

View Our Latest Report on IperionX

Institutional Investors Weigh In On IperionX

A number of institutional investors have recently bought and sold shares of IPX. Private Advisor Group LLC lifted its stake in IperionX by 69.9% in the first quarter. Private Advisor Group LLC now owns 63,111 shares of the company's stock valued at $1,643,000 after acquiring an additional 25,964 shares during the last quarter. DLD Asset Management LP bought a new position in shares of IperionX in the 1st quarter worth about $260,000. Connective Capital Management LLC purchased a new stake in IperionX in the 2nd quarter worth about $160,000. Finally, GAMMA Investing LLC raised its holdings in IperionX by 40.3% during the 2nd quarter. GAMMA Investing LLC now owns 1,681 shares of the company's stock valued at $50,000 after buying an additional 483 shares during the last quarter. 2.76% of the stock is currently owned by hedge funds and other institutional investors.

IperionX Stock Down 0.8%

Shares of IPX opened at $14.10 on Friday. The company has a current ratio of 3.24, a quick ratio of 2.95 and a debt-to-equity ratio of 0.04. The company has a 50-day moving average of $17.29 and a two-hundred day moving average of $29.64. IperionX has a one year low of $12.14 and a one year high of $61.45.

IperionX (NASDAQ:IPX - Get Free Report) last issued its earnings results on Thursday, July 30th. The company reported ($0.50) earnings per share (EPS) for the quarter. As a group, equities analysts anticipate that IperionX will post -0.34 earnings per share for the current year.

About IperionX

(Get Free Report)

IperionX Limited NASDAQ: IPX is a critical minerals and advanced materials company focused on producing low-carbon titanium products in the United States. The company is developing domestic sources of titanium minerals and technologies intended to convert titanium feedstocks into titanium metal, powder and other advanced materials.

IperionX's primary development asset is the Titan Project in Tennessee, which contains titanium, zircon and other heavy mineral sands. The company is also developing proprietary processing technologies, including the Hydrogen-Assisted Metallothermic Reduction (HAMR) process and the Titanium Alloy Production (TAP) process, with the goal of manufacturing titanium products using less energy than conventional production methods and incorporating recycled titanium where practical.

The company targets customers in industries such as aerospace, defense, medical devices, automotive, consumer products and additive manufacturing.

Read More

Analyst Recommendations for IperionX (NASDAQ:IPX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in IperionX Right Now?

Before you consider IperionX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IperionX wasn't on the list.

While IperionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines